این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
پژوهش‌های آسیب‌ شناسی زیستی، جلد ۲۸، شماره ۲، صفحات ۷-۱۲
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Drug-drug interactions in pharmacotherapy of heart failure: Risk of electrolyte abnormalities
چکیده انگلیسی مقاله Heart failure (HF) is associated with several systemic complications that require combination therapies. Considering the type and clinical manifestations of HF, several types of medications are used to overcome some harmful activated compensatory mechanisms. Angiotensin receptor–neprilysin inhibitors (ARNIs), angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs) and sodium–glucose cotransporter 2 (SGLT2) inhibitors alongside with other classes like diuretics, vasodilators and/or positive inotropic agents constitute the medication basket for patients with heart failure. Polypharmacy with different classes of drugs increases the risk of drug-drug interactions during treatment. One of the main issues in these interactions is the risk of electrolyte abnormalities, especially regarding the potassium level, which would be so threatening. This mini review focused on specific aspects of drug-drug interactions that might occur during treatment and how they can be life-threatening.

کلیدواژه‌های انگلیسی مقاله Heart failure,ARNIs,SGLT2 inhibitors,ARBs,ACEIs,Drug-interaction,Electrolyte abnormalities
نویسندگان مقاله Azadeh Khalili |
Evidence-based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran Department of Physiology-Pharmacology-Medical Physics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

Hossein Karim |
Cardiovascular research center, Alborz University of Medical Sciences, Karaj, IranDepartment of Cardiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

Mahdi Goudarzvand |
Department of Physiology-Pharmacology-Medical Physics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

Gholamreza Bayat |
Evidence-based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran Department of Physiology-Pharmacology-Medical Physics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

نشانی اینترنتی https://mjms.modares.ac.ir/article_19536_cab15693856f8a5c8d87a20d2a0b7922.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات